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Hippo-like pathways are ancient signaling modules
first identified in yeasts. The best-defined metazoan
module forms the core of the Hippo pathway, which
regulates organ size and cell fate. Hippo-like kinase
modules consist of a Sterile 20-like kinase, an NDR
kinase, and non-catalytic protein scaffolds. In the
Hippo pathway, the upstream kinase Hippo can be
activated by another kinase, Tao-1. Here, we delin-
eate a related Hippo-like signaling module that
Tao-1 regulates to control tracheal morphogenesis
in Drosophila melanogaster. Tao-1 activates the
Sterile 20-like kinase GckIII by phosphorylating its
activation loop, a mode of regulation that is
conserved in humans. Tao-1 and GckIII act upstream
of the NDR kinase Tricornered to ensure proper tube
formation in trachea. Our study reveals that Tao-1 ac-
tivates two related kinase modules to control both
growth andmorphogenesis. The Hippo-like signaling
pathway we have delineated has a potential role
in the human vascular disease cerebral cavernous
malformation.
INTRODUCTION
Signaling pathways that contain a Sterile 20-like kinase that
activates a nuclear Dbf2-related (NDR) family kinase exist
throughout eukaryotes, regulate different biological processes,
and are sometimes referred to as Hippo-like signaling modules
(Hergovich and Hemmings, 2012). Antecedent examples of this
type of kinase module include the Saccharomyces cerevisiae
mitotic exit network and the Schizosaccharomyces pombeDeveseptation initiation network, which control cell division and cyto-
kinesis (Bardin and Amon, 2001). The best-defined signaling
module of this kind in metazoans forms the core of the Hippo
pathway, which operates in insects andmammals to control pro-
cesses such as organ size and cell fate (Pan, 2010; Halder and
Johnson, 2011; Harvey et al., 2013). In addition, a related
pathway has been identified in mammals and consists of the
Sterile 20-like kinase Mammalian Sterile Twenty-like 3 (MST3)
(and possibly its close homologs MST4 and STK25), which can
regulate the NDR family kinases NDR1 and NDR2 (aka STK38
and STK38L) (Hergovich, 2013). In some instances, Sterile
20-like kinases have been reported to regulate more than one
type of NDR family kinase. For example, Hippo (Hpo) can
regulate both Tricornered (Trc) and Warts (Wts) in Drosophila
melanogaster peripheral nervous system dendrites (Emoto
et al., 2006). In addition, in mammals, the Hpo orthologs MST1
and MST2 can regulate both the Trc orthologs NDR1 and
NDR2 and the Wts orthologs LATS1 and LATS2 (Yu and Guan,
2013; Hergovich and Hemmings, 2009; Avruch et al., 2012).
The sole D. melanogaster ortholog of NDR1/2, Trc, controls
hair and bristle development in the wing, thorax, and antennae,
as well as dendrite tiling and branching in the peripheral
nervous system (Geng et al., 2000; Emoto et al., 2006). In
D. melanogaster, the sole ortholog of MST3/MST4/STK25,
Germinal center kinase III (GckIII), regulates tracheal develop-
ment together with the non-catalytic protein Cerebral cavernous
malformation 3 (CCM3). Loss of GckIII results in a characteristic
dilation at the transition zone of the terminal cell, associated with
abnormal localization and abundance of septate junction pro-
teins and the apical membrane protein Crumbs (Song et al.,
2013). The mechanism by which GckIII is regulated in trachea
is unknown, and it is also unclear whether GckIII controls
tracheal development by regulating an NDR family kinase.
Kinases belonging to the Thousand and one (Tao) family are
conserved throughout evolution. Three Tao proteins are en-
coded in the human genome (TAO1, TAO2, and TAO3), whilelopmental Cell 47, 1–12, December 3, 2018 ª 2018 Elsevier Inc. 1
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(Tao-1). Like Hpo and GckIII, Tao kinases belong to the Sterile
20-like kinase family. Tao kinases have been linked to multiple
functions including control of organ growth and stem cell prolif-
eration via the Hippo pathway (Boggiano et al., 2011; Poon et al.,
2011; Poon et al., 2016), epithelial cell shape, animal behavior,
and microtubule polymerization (Liu et al., 2010; King et al.,
2011; Gomez et al., 2012). The substrates of Tao kinases, and
thereby the mechanism by which they regulate these processes,
are less well defined. Perhaps the best-characterized Tao-1 sub-
strate is the Hpo kinase; Tao-1 activates Hpo by phosphorylating
its activation loop, and this phosphorylation event is conserved
in human cells between the orthologous kinases TAO1 and
MST2 (Boggiano et al., 2011; Poon et al., 2011). Tao-1 can
also activate the related Sterile 20-like kinase Misshapen in the
D. melanogaster midgut (Li et al., 2018). When active, Hpo can
phosphorylate the hydrophobic motif of the NDR family kinase
Wts, which triggers Wts autophosphorylation and activation
(Pan, 2010; Li et al., 2018). Likewise, the human Hpo orthologs
MST1 and MST2 can phosphorylate and regulate the activity
of the Wts orthologs LATS1 and LATS2 (Praskova et al., 2008).
The D. melanogaster respiratory system, or trachea, is
composed of a simple epithelium arranged into tubes of three
distinct architectures (Samakovlis et al., 1996). The smallest
tubes form within the terminal cells of the tracheal system and
are morphologically similar to the seamless endothelial tubes
found in the vertebrate vascular system (Yu et al., 2015). Within
terminal cells, there is a region termed the transition zone,
wherein a tube containing an auto-cellular junction connects to
a seamless tube. This seamless tube extends distally and
branches dozens of times to ramify extensively on internal
tissues where the tubes serve as the primary site of gas ex-
change. In prior studies, we determined that terminal cells lack-
ing CCM3 or GckIII function show dramatic tube dilation within
this transition zone (Song et al., 2013).
In humans, CCM3 is one of three genes known to be affected
in cases of familial cerebral cavernous malformations. CCM3
binds to members of the GCKIII subfamily of Sterile 20-like ki-
nases, of which there are three in humans (Draheim et al.,
2014). The ability of CCM3 to bind GCKIII family members is
thought to be essential to its function (Zalvide et al., 2013), and
in flies, which have a single extant GCKIII family member, loss
of GCKIII and CCM3 have identical consequences for the
tracheal system (Song et al., 2013). Likewise, CCM3 and GCKIII
have been shown to function together in zebrafish and nema-
todes (Yoruk et al., 2012; Zalvide et al., 2013; Lant et al., 2015).
Despite much progress, the precise mechanism by which loss
of CCM3 leads to tube dilation remains unknown, and likewise,
the substrates of GCKIII family members in the vascular system
remain mysterious.
Using protein affinity purification andmass spectrometry as an
unbiased approach, we identified GckIII as a binding partner of
Tao-1. Analogous to the way that Tao-1 activates Hpo, we found
that Tao-1 phosphorylates and activates GckIII and that this rela-
tionship is conserved in human cells. Even more importantly, we
show that Tao-1 andGckIII function together with the NDR family
kinase Trc to regulate tube formation in trachea. Therefore, our
study shows that Tao-1 regulates distinct biological processes
by activating two related Hippo-like signaling modules contain-2 Developmental Cell 47, 1–12, December 3, 2018ing a Sterile 20-like kinase and an NDR family kinase. The fact
that Tao kinases regulate both organ growth andmorphogenesis
suggests that they could serve as key signaling nodes that
couple both of these processes during organogenesis.
RESULTS
Tao-1 Binds to GckIII Kinase and Phosphorylates Its
Activation Loop in D. melanogaster Cells
To identify potential targets of the Tao-1 kinase, we generated
D. melanogaster S2 cell lines that stably expressed Tao-1 fused
to an affinity tag at the N terminus (see STAR Methods). Tao-1
was affinity purified and subjected to mass spectrometry.
Among the proteins retrieved with the highest abundance was
the Sterile 20-like kinase GckIII. We identified 35 and 12 GckIII
peptides in two independent experiments (0 peptides in six con-
trol samples), with a SAINT (Choi et al., 2011) probability of 1,
indicating a highly significant interaction (Table S1).
We pursued potential regulatory links between Tao-1 and
GckIII because, based on sequence homology, the GckIII kinase
is most closely related to Hpo, another Sterile 20-like kinase that
we and others previously discovered to be regulated by Tao-1 in
the context of epithelial tissue growth (Poon et al., 2011; Bog-
giano et al., 2011). Initially, we confirmed that Tao-1 can form a
physical complex with GckIII by performing co-immunoprecipi-
tation experiments in D. melanogaster S2R+ cells. N-terminally
tagged versions of hemagglutinin (HA)-Tao1 and myc-GckIII
(both wild-type and kinase-dead versions for each) were co-ex-
pressed, followed by immunoprecipitation using anti-HA. This
revealed that irrespective of their activity status, Tao-1 andGckIII
can form a complex in D. melanogaster cells, as judged by the
co-immunoprecipitation of both wild-type and kinase-dead
variants (Figure 1A).
Next, considering that Tao-1 activates the closely related ki-
nase Hpo by phosphorylating its T-loop (activation loop) (Bog-
giano et al., 2011; Poon et al., 2011), we tested whether Tao-1
can also phosphorylate GckIII. To do so, we pursued two lines
of research. First, we examined the impact of Tao-1 expression
on phosphorylation of the GckIII activation loop (Thr167, which is
highly conserved between D. melanogaster and human ortho-
logs [Figure 1B]) in S2R+ cells. Indeed, Thr167 phosphorylation
of kinase-dead GckIII was substantially elevated upon co-
overexpression of Tao-1 (Figure 1C). Second, we studied Tao-
1-mediated in vitro phosphorylation of recombinant full-length
kinase-dead GckIII. Consistent with our cell-based studies,
expression of wild-type but not kinase-dead Tao-1 phosphory-
lated the activation loop of GckIII (Figure 1D). Collectively, these
experiments suggest that Tao-1 can phosphorylate GckIII at
residue Thr167 of its activation loop, a molecular event known
to trigger the activation of Sterile 20-like kinases (Glantschnig
et al., 2002; Deng et al., 2003).
TAO1 Binds to GCKIII Kinases in Human Cells and
Phosphorylates Their Activation Loop
Considering that GCKIII is conserved between D. melanogaster
and humans, and that the Tao-1/Hippo regulatory relationship
is conserved between D. melanogaster and humans (Boggiano
et al., 2011; Poon et al., 2011), we asked next whether human
TAO1 interacts with and phosphorylates MST3, MST4, and/or
Figure 1. D. melanogaster Tao-1 Kinase Binds and Phosphorylates GckIII Kinase on Its Activation Loop
(A) Lysates of D. melanogaster S2R+ cells expressing wild-type (wt) or kinase-dead (kd) HA-Tao-1 together with wt or kd myc-GckIII were subjected to
immunoprecipitation (IP) using anti-HA antibodies. Immunoprecipitates and input lysates were analyzed by immunoblotting with the indicated antibodies.
(B) Alignment of the conserved T-loop of D. melanogaster (dm) and human (hs) GCKIII kinase sequences. Identical residues are highlighted in yellow. The
positions of the regulatory T-loop phosphorylation sites are indicated. The T-loop phosphorylation site of GCKIII kinases is conserved in flies and humans.
(C) S2R+ cells were transfected with the indicated plasmids and immunoblotted using anti-T167-P (top), anti-myc (top middle), anti-HA (bottom middle), and
anti-actin (bottom) antibodies.
(D) Lysates of S2R+ cells transiently expressing HA-Tao-1 variants were subjected to immunoprecipitation with anti-HA antibodies. Immunopurified proteins
were then used in kinase assays with or without the indicated recombinant versions of Mal-GckIII. Following kinase reactions, the samples were immunoblotted
with the indicated antibodies. The anti-T167-P antibody specifically detected Tao1-mediated phosphorylation of GckIII on Thr167 (compare lanes 3, 9, and 11).
Relative molecular masses are shown in kDa for each blot.
See also Table S1.
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(hereafter, collectively termed hGCKIII) (Dan et al., 2001). The
corresponding hGCKIII and TAO1 cDNAs were expressed in
human HEK293 cells and TAO1/hGCKIII complex formation
assessed by co-immunoprecipitation experiments. As shown
in Figure 2A, TAO1 formed a complex with all three GCKIII
homologs. These results are consistent with an unbiased high-
throughput protein-protein interaction study that identified phys-
ical interactions between TAO1 and STK25, as well as TAO2 and
STK25 (TAO2 is a homolog of TAO1) (Huttlin et al., 2015).
Subsequently, we investigated whether human TAO1 phos-
phorylates the activation loop of hGCKIII kinases in human cells
and in vitro. We observed activation loop phosphorylation of
hGCKIII in immunoprecipitates from cells that were co-trans-
fected with TAO1 and hGCKIII kinases (Figure 2A). We observed
similar results when assessing TAO1’s ability to induce activa-
tion loop phosphorylation of endogenous hGCKIII (Figure 2B).
Furthermore, this was dependent on TAO1’s kinase activity as
expression of kinase-dead TAO1 had no impact on hGCKIII acti-vation loop phosphorylation (Figure 2B). In parallel, we per-
formed in vitro kinase assays using recombinant full-length
kinase-dead hGCKIII proteins as substrates. We observed
hGCKIII activation loop phosphorylation by wild-type, but not
kinase-dead, TAO1 immunoprecipitates (Figure 2C). Taken
together, our data suggest that GckIII kinases are bona fide sub-
strates of Tao kinases in both D. melanogaster and human cells.
GCKIII Does Not Regulate Tissue Growth via the Hippo
Pathway
We next explored the biological setting in which Tao-1 regulates
GckIII, by examining control of tissue growth by the Hippo
pathway. Tao-1 controls epithelial tissue growth by activating
the Hpo kinase by phosphorylating its activation loop (Boggiano
et al., 2011; Poon et al., 2011). When active, Hpo phosphorylates
the other members of the Hippo pathway core kinase cassette
Salvador, Mats, and Wts (Pan, 2010; Harvey et al., 2013; Halder
and Johnson, 2011). Wts phosphorylates the transcriptional
co-activator protein Yorkie (Yki), thus limiting its access to theDevelopmental Cell 47, 1–12, December 3, 2018 3
Figure 2. TAO1 Kinase Binds and Phos-
phorylates GCKIII Kinases on Their Activa-
tion Loop in Human Cells
(A) Lysates of human HEK293 cells expressing
HA-GCKIII kinases (MST3, MST4, or STK25)
together with myc-TAO1 were subjected to
immunoprecipitation using anti-HA antibodies,
before immunoblotting with the indicated anti-
bodies.
(B) HEK293 cells expressing wt or kd human TAO1
were lysed and immunoblotted with the indicated
antibodies.
(C) Lysates of HEK293 cells expressing human
wild-type (wt) or kinase-dead (kd) HA-TAO1 were
subjected to immunoprecipitation with anti-HA
antibodies. Immunopurified kinases were used in
kinase assays with or without the indicated re-
combinant wt or kd Mal-GCKIII kinases. Following
kinase reactions, samples were examined by
immunoblotting with the indicated antibodies.
TAO1-mediated activation loop phosphorylation
of human GCKIII kinases was observed only when
wt TAO1 was incubated with kd GCKIII kinases.
Relative molecular masses are shown in kDa for
each blot.
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promote tissue growth (Pan, 2010; Harvey et al., 2013; Halder
and Johnson, 2011). Recently, Misshapen and Happyhour,
which also belong to the Sterile 20-like kinase family, were
shown to act in parallel to Hpo to promote Wts activity (Zheng
et al., 2015; Meng et al., 2015; Li et al., 2014). Given that GckIII
is the closest homolog of Hpo, we investigated the possibility
that it also functions in parallel to Hpo to control Hippo
pathway-dependent growth of epithelial tissues.
Initially, we assessed whether loss of GckIII, using either RNAi
or mutant alleles, displayed tissue overgrowth, a characteristic
feature of Hippo pathway genes (Tapon et al., 2002). Unlike the
overgrown adult eyes harboring clones of hpo mutant tissue
(Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003;
Wu et al., 2003; Jia et al., 2003), GckIII mutant genetic mosaic
adult eyes were rough and smaller in size than the control eyes
(Figures S1A and S1B). Furthermore, depletion of GckIII by
RNAi in the developing wing disc caused a reduction in the
size of the adult wing, as opposed to overgrowth that might
be expected should GckIII act similarly to Hpo (Figures
S1C–S1E). Loss of Hippo pathway proteins causes Yki hyperac-
tivation and elevated expression of DIAP1 (Huang et al., 2005).
Using hsFLP MARCM (Lee and Luo, 1999), we generated GFP-
marked clones in third instar larval wing imaginal discs that either
harbored homozygous hpo5.1 null (Genevet et al., 2009) mutant
clones or expressed GckIII RNAi. However, GckIII depletion did
not induce changes in DIAP1, as opposed to the increased
DIAP1 expression observed upon loss of hpo (Figures S1F–
S1G0). We considered the possibility that Hpomight compensate
for GckIII in its absence and mask a role for GckIII in promoting
Wts activity to limit tissue growth. To test this, we depletedGckIII
by RNAi in hpo5.1 null clones using the eyFlp MARCM system.
The degree of tissue overgrowth was similar in adult eyes and4 Developmental Cell 47, 1–12, December 3, 2018head containing hpo null clones as it was in hpo null clones
that also expressed a GckIII RNAi transgene (Figures S1H
and S1I). Similar results were obtained when comparing the
size of clones generated in third instar larval wing imaginal discs
using the hsFlp MARCM system (Figures S1J–S1N). Therefore,
we conclude that GckIII does not regulate Hippo pathway-
dependent growth of epithelial tissues. These findings are
consistent with recent biochemical studies of Zheng et al., who
reported that, in contrast to Hpo, GckIII does not phosphorylate
Wts or regulate its activity in D. melanogaster cultured cells
(Zheng et al., 2015). To investigate the apparent undergrowth
of GckIII mutant tissue, we assessed both cell proliferation and
apoptosis in developing eye imaginal discs. While we observed
no discernible change in cell proliferation (Figures S2A–S2D0)
of GckIII mutant eye cells, we did observe an increased number
of apoptotic cells (Figures S2E–S2H0) consistent with previous
observations of GckIII depletion in the wing imaginal disc
(Friedman and Perrimon, 2006). Collectively, this indicates that,
unlike Hpo, GckIII does not normally suppress growth of eye or
wing imaginal discs.
Tao-1 Kinase Regulates Tube Structure in
D. melanogaster Trachea
We then investigated a role for Tao-1 in tracheal development,
given that we had previously found that GckIII mutations lead
to dilation of the tube within the terminal cell transition zone in
larval trachea (Song et al., 2013). Three tube types are found in
D. melanogaster trachea: multi-cellular, auto-cellular, and seam-
less tubes (Figure 3A). In trachea, terminal cells (composed of
seamless tubes) connect to and branch out from stalk cells
(composed of auto-cellular tubes) at an intercellular junction
(arrow, Figure 3A0). The region positioned between the inter-
cellular junction (arrow) and terminal cell nucleus is known as
Figure 3. Tao-1 Regulates Development ofD.melanogaster Trachea
(A and A0 ) Schematic illustration of D. melanogaster trachea, which comprise
three different tube architectures: seamless tubes, auto-cellular tubes, and
multi-cellular tubes (cross sections represented in (A). (A0) A depiction of part of
a terminal cell (a seamless tube) that joins to an auto-cellular stalk cell at the
transition zone (marked by bracket), which is located between an intracellular
junction (marked by arrow) and the nucleus. Nucleus is brown; cytoplasm is
gray; septate junctions are pink; adherens junctions are purple; apical lumens
are orange (adapted from Song et al., 2013).
(B–D%) Wild-type (B–B%) or Tao-1eta (C–D%) terminal cell clones, marked by
GFP (green). Boxed areas in (B), (C), and (D0 ) are shown as close-up images
in (B%), (C%), and (D%). Brightfield (BF) images are shown in (B0), (C0), (D0), and
(D%) and the merged images (B00), (C00), and (D00). (B–B%) Gas-filled tubes that
pierce the cytoplasm are evident in the wild-type terminal cell. The tube ex-
tends beyond the clone through the unmarked neighboring stalk cell. (C–C%)
Loss of Tao-1 results in prominent dilations (*) in the transition zone of 73% of
terminal cells scored (D–D%) A Tao-1eta terminal cell clone that displays a
‘‘gap’’ defect, in which a portion of the terminal cell tube is absent within the
transition zone (bracket). The cell also displays several small tube dilations
(marked by *). Scale bars, 20 mm.
See also Figures S1–S3 and Table S2.
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from seamed to seamless tubes (Song et al., 2013; Samakovlis
et al., 1996). We generated Tao-1 loss-of-function clones in tra-
chea using the hsFLP-GFP system (Ghabrial et al., 2011) and the
Tao-1eta allele (Gomez et al., 2012). Strikingly, we observed tran-
sition zone tube dilation in 73% of terminal cells and transition
zone tube gaps (or restrictions) in 26% of terminal cells (1 termi-
nal cell showed both a local dilation and a gap) (Figures 3B–3D%
and Table S2). We also observed small bulges in the seamless
tubes of multiple tracheal terminal cells (Figures 3D–3D%),
consistent with the GckIII loss-of-function phenotype we re-
ported previously (Song et al., 2013).
To confirm these results, we used two independent Tao-1
RNAi lines that we have previously employed to deplete this pro-
tein in epithelial tissues and neural stem cells (Poon et al., 2011,
2016). Similar to what we observed using the classical loss-of-
function allele, when Tao-1 was depleted by RNAi in trachea
using btl-GAL4, we observed transition zone dilations (Figures
S3A–S3A%). Transition zone dilations were observed in 74% of
Tao-1 RNAi-expressing terminal cells, transition zone gaps in
12% of terminal cells, and no gross morphological defects in
14% of terminal cells (n = 34) (Figures S3A–S3B% and
Table S2). Furthermore, we assessed hpo42–47 mutant clones
in trachea and observed no dilations in terminal cells (either in
transition zones or terminal cell branches; Figures S3C–S3C%
and Table S2) suggesting that Tao-1 and Hippo perform distinct
functions in tracheal development. Collectively, these data
show that Tao-1 is an essential regulator of tracheal develop-
ment and that Tao-1 loss largely phenocopies GckIII loss in
this tissue.
Tao-1 Regulates the Abundance and Localization of
Junctional and Apical Proteins in Trachea
Given our biochemical evidence that Tao-1 binds to and acti-
vates GckIII and that loss of either Tao-1 or GckIII causes transi-
tion zone dilation in trachea, we asked whether loss of Tao-1
results in abnormal localization of junctional and apical proteins,
as was reported for Ccm3 andGckIIImutants (Song et al., 2013).
The transition zone of wild-type trachea contains septate and
adherens junctions in the proximal part of the terminal cell
(Song et al., 2013; Samakovlis et al., 1996). This small stretch
of auto-cellular tube in terminal cells is frequently remodeled
away by the third larval instar, but it tends to persist in Ccm3
and GckIII mutant cells and is evident by ectopic expression of
septate junction proteins (Song et al., 2013). We observed a
similar perdurance of auto-cellular junctions in Tao-1 mutant
terminal cells, which displayed ectopic expression of septate
junction proteins such as Fasciclin 3 (Fas 3) and Varicose (Vari)
(arrowheads in Figures 4A–4D00).
InCcm3 andGckIIImutant terminal cells, the apical membrane
protein Crumbs, which is normally present only in discrete
puncta along the apical membranes of the terminal cell, accumu-
lates at high levels on these membranes (Figures 4E–4E0; Song
et al., 2013). Compared to Crumbs-GFP localization in wild-
type terminal cells, Crumbs-GFP was more highly expressed
and lined the majority of the apical lumen of terminal cells
expressing Tao-1 RNAi (Figures 4F–4F0). These data strongly
suggest a common molecular defect underlies the transition
zone dilation caused by loss of either GckIII or Tao-1.Developmental Cell 47, 1–12, December 3, 2018 5
Figure 4. Tao-1 Prevents Ectopic Accumu-
lation of Septate Junction Proteins and
Crumbs in Trachea
(A–D00) Terminal cell clones of the indicated genotypes
marked byGFP and stained for antibodies specific for
Fas3 (red) or Varicose (white). The arrow indicates the
intercellular junction. (A–A00) and (C–C00) are from the
same double stained terminal cell clone. In wild-type
terminal cell GFP-positive clones (green), Fas3 (A–A00,
red) and Varicose (C–C00, white) are expressed at the
septate junction of the autocellular tube and at the
intercellular junction (arrow). Incomparison, inTao-1eta
terminal cell clones, ectopic Fas3 (B–B00, red) and
ectopicVari (D–D00,white)areobserved in thetransition
zone dilation (indicated by *) and in more distal posi-
tions of the cell (indicated by arrowheads, B and D).
(E and F0) Terminal cells with Crumbs-GFP (green)
stained with antibodies specific for Wkd (magenta)
to mark tracheal tubes. In wild-type terminal cells
(E–E0), Crumbs-GFP (green, E–E0 ) decorates the
lumenal membrane (Wkd, magenta, E0) in well-
spaced foci. In comparison, in terminal cells
expressingTao-1RNAiwithbtl-Gal4 (F–F0), Crumbs-
GFP levels (green, F–F0) were elevatedandappeared
to almost continuously line the lumenal membrane
(marked by Wkd, magenta, F–F0).
Scale bars, 20 mm.
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Coupled with the finding that Tao-1 forms a complex with GckIII
and phosphorylates the GckIII activation loop (Figures 1 and 2),
our observations are consistent with the notion that these pro-
teins operate together to control tracheal morphogenesis. To
investigate this further, we assessed the epistatic relationship
between Tao-1 and GckIII in vivo. We used the MARCM system
to generate tracheal terminal cells that were mutant for GckIII,
using a GckIIIwheezy molecular null mutant allele (Song et al.,
2013), and also expressed a hyperactive Tao-1 allele (Tao-1HA),
where a central inhibitory domain had been removed (Liu et al.,
2010) (Figure 5A). Expression of Tao-1HA in terminal cells using
drm>GFP had no discernible phenotype (Figures S3A–S3A%
and Table S2) and failed to rescue the transition zone dilations
associated with the GckIIIwheezy allele, consistent with Tao-1’s
operating upstream of GckIII (Figures 5B–5C00 and Table S2).
We tested this further by utilizing a hyperactive GckIII transgene
(GckIIIHA), where the activation loop residue at position 167 was
mutated from threonine to aspartic acid, which mimics phos-
phorylation of this residue (Figure 5A). Expression of GckIIIHA
alone largely causes a mild wavy lumen phenotype (Figure S4B
and Table S2), and co-expression of GckIIIHA in Tao-1eta mutant6 Developmental Cell 47, 1–12, December 3, 2018terminal cells partially rescued pheno-
types associated with Tao-1 loss,
including dilation of the transition zone
(Figures 5D–5D00 and Table S2). Phos-
phorylation at T167 is essential for GckIII
function since expression of a mutant
version of GckIII (GckIIIT167A), where
T167 is mutated to alanine thus rendering
this site unable to be phosphorylated, re-sulted in dilations in 66% of terminal cells scored (Figures 5E–
5E00 and Table S2). Together with our biochemical data (Figures
1 and 2), these epistasis studies indicate that GckIII functions
downstream of Tao-1 in tracheal terminal cells.
GCKIII Phosphorylates the Hydrophobic Motif of
Tricornered to Regulate Tracheal Development
Given the architecture of Hippo-like signaling modules, we pre-
dicted that an NDR family kinase would operate downstream
of GckIII in trachea. D. melanogaster has two such kinases:
Wts and Trc. We considered Trc to be the lead candidate
because of two prior results obtained by our groups: (1) the hu-
man GCKIII ortholog MST3 phosphorylates the hydrophobic
motif of the human Trc orthologs, NDR1 and NDR2, an essential
step in their activation (Stegert et al., 2005; Cornils et al., 2011),
and this motif is conserved in Trc/NDR kinases in flies and hu-
mans (Figure 6A); and (2)wtsmutant trachea display overgrowth
phenotypes (Ghabrial et al., 2011), which are distinct from the
tracheal dilations observed upon GckIII or Tao-1 loss (Song
et al., 2013) (Figures 3C and 5B).
Initially, we sought to determine whether the reported
biochemical relationship between hGCKIII and NDR1/2 was
conserved between the D. melanogaster and human orthologs.
Figure 5. GckIII Functions Epistatically to Tao-1 in Trachea
(A) Schematic of Tao-1 and GckIII wild-type and mutant transgenes utilized for
genetic epistasis experiments. Blue boxes indicate a kinase domain, and
green boxes indicate coiled-coil domains. Wild-type Tao-1 contains a kinase
domain at the N terminus and 3 coiled-coil domains at the C terminus.
Hyperactive Tao-1 (Tao-1HA) contains a deletion in the central region (amino
acids 423–900). Wild-type GckIII contains a kinase domain at the N terminus;
hyperactive GckIII (GckIIIHA) contains a point mutation where T is mutated to D
to mimic phosphorylation at 167 in the activation loop of the kinase domain;
and dominant negative GckIII (GckIIIDN) contains a point mutation where T is
mutated to A to prevent phosphorylation at 167 in the activation loop of the
kinase domain.
(B–E) Terminal cell clones of the indicated genotypes are marked by GFP
(green) with accompanying brightfield (BF) images. Transition zone tube di-
lations are marked by an asterisk (*).
(B–B00) GckIIIwheezy terminal cell clones, marked by GFP (green). Transition
zone tube dilations (*) are observed in 100% of GckIIIwheezy mutant clones
scored.
(C–C00) A GckIIIwheezy terminal cell clone (marked by GFP) expressing a hy-
peractive Tao-1 (Tao-1HA) transgene. Expression of hyperactive Tao-1 failed to
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dead GckIII were subjected to immunoprecipitation with anti-HA
antibodies, and immunopurified proteins were incubated with
the recombinant Mal-tagged hydrophobic motif fragment of
Trc. Following in vitro kinase reactions, samples were examined
by immunoblotting, using antibodies that detect phosphorylation
of the hydrophobic motif of Trc (Thr449). We observed robust
phosphorylation of this residue (Figure 6B), showing, for the first
time in D. melanogaster, that GckIII can phosphorylate the hy-
drophobic motif of Trc and suggesting that this regulatory rela-
tionship is conserved between flies and mammals. To determine
whether phosphorylation was direct as opposed to an inter-
mediate kinase, we performed in vitro kinase assays using re-
combinant human kinases (NDR1 and NDR2 as substrates and
MST1-4 and STK25 as kinases). We found that all three human
GCKIIIs (MST3, MST4, and STK25) as well MST1 and MST2
(the human Hpo orthologs) can phosphorylate human NDR1
andNDR2 to differing degrees on Thr444 and Thr442 (Figure 6C),
their respective hydrophobic motif phosphorylation sites that are
essential for NDR1/2 activation (Hergovich, 2013, 2016). Taken
together, our data show that Trc/NDR kinases are substrates
of GCKIII kinases in both flies and humans.
To investigate the function of Trc in trachea, we used drm-
GAL4 to express trc RNAi transgenes or examined clones of
the classic trc1 allele (Geng et al., 2000) in trachea terminal cells.
Strikingly, we observed tracheal dilation phenotypes in the tran-
sition zone of trc1 terminal cells (98% of 44 terminal cell clones
examined; Figures 6D–6D00 and Table S2), which closely phe-
nocopied those observed upon loss of either GckIII or Tao-1.
Consistently, expression of trc RNAi under control of drm-
GAL4 at 29C induced a high frequency of transition zone dila-
tions, while a small number of tubes also displayed a gap defect
in the transition zone (Table S2 and Figure S5). All terminal cells
mutant for trc or expressing trc RNAi were also defective in
gas filling (Figures 6D–6D00 and Table S2). Gas-filling defects
are frequently found among mutations affecting terminal cell
morphology, and similar gas-filling defects were seen at a very
low frequency in GckIII mutant terminal cells (Ghabrial et al.,
2011). As with terminal cells mutant for either GckIII or Tao-1,
we observed ectopic expression of different septate junction
proteins upon RNAi-mediated depletion of trc. In drm-GAL4,
trc RNAi terminal cells, ectopic Fas3 expression was evident
(Figures 6E–6E00), as was ectopic Coracle staining (Figures
6F–6F00), and similar data were observed in trc1 clones (data
not shown). Upon trc depletion, we also observed substantial
elevation of Crumbs-GFP expression, which lined the majority
of the lumen of trc RNAi terminal cells (Figures 6G–6G00). Consis-
tent with Trc acting downstream of GckIII in trachea, expressionrescue transition zone dilations inGckIIIwheezymutant cells, and transition zone
tube dilations were observed in 100% of terminal cells scored.
(D–D00) A Tao-1eta terminal cell clone (marked by GFP) expressing a hyperac-
tive GckIII (GckIIIHA) transgene. Expression of hyperactive GckIIIHA in Tao-1eta
mutant clones caused transition zone tube dilations in 51% of terminal cells
scored.
(E–E00) Expression of aGckIII transgene bearing the pointmutation T167A in the
activation loop (GckIIIT167A) results in transition zone tube dilations in 66% of
terminal cells scored.
Scale bars, 20 mm.
See also Figure S4 and Table S2.
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Figure 6. The Tricornered Kinase Is Phos-
phorylated on Its Hydrophobic Motif by
GckIII and Regulates Tracheal Development
(A) Alignment of the hydrophobic motif of
D. melanogaster (dm) and human (hs) NDR kinase
sequences. Identical residues are highlighted in
yellow. The positions of the regulatory hydropho-
bic motif phosphorylation sites are indicated. The
hydrophobic motif phosphorylation site of Trc/
NDR kinases is conserved from flies to humans.
(B) Lysates of S2R+ cells transiently expressing
wild-type (wt) or kinase-dead (kd) HA-GckIII
were immunoprecipitated with anti-HA antibodies
and incubated with a recombinant Mal-tagged
hydrophobic motif fragment of Trc (Mal-Trc[HM])
in kinase assays. Subsequently, samples were
examined by immunoblotting using the indicated
antibodies. Relative molecular masses are shown
in kDa for each blot.
(C) Recombinant glutathione S-transferase (GST)-
tagged wild-type full-length MST kinases (MST [1],
MST2 [2], MST3 [3], MST4 [4], or STK25 [25], with
respective abbreviations in square brackets) were
incubated with recombinant Mal-tagged hydro-
phobic motif fragments of human NDR1 or NDR2
(Mal-NDR1/2 [HM]). Following kinase reactions,
the samples were analyzed by western blotting
using the indicated antibodies. Relative molecular
masses are shown in kDa for each blot.
(D–D00) A trc1 terminal cell clone marked by GFP
(green). Brightfield (BF) images are shown in (D0)
and the merged image (D00). The * indicates a
prominent transition zone dilation. The terminal
cell also exhibits a gas-filling defect and is outlined
with a white dashed line in (C0) and (C00).
(E–E00) Terminal cell expressing a trc RNAi (trcRi)
transgene using btl-GAL4 (marked by GFP) and
stained for Fas3 (red). Large dilations (*) in the
transition zone were readily detected, and ectopic
Fas3 is present in the transition zone dilation
(arrowheads) of Tao-1eta terminal cell clones and
more distally as well (arrowheads).
(F–F00) Terminal cells marked with GFP (green)
expressing a trc RNAi (trcRi) transgene using drm-
GAL4 and stained for Coracle (magenta) displayed
ectopic localization of Coracle in the transition
zone (arrowheads) and distally (data not shown).
Arrows mark intercellular junction.
(G–G00) Terminal cell (tubes visualized with UV)
expressing a trc RNAi (trcRi) transgene using drm-
GAL4with Crumbs-GFP almost continuously lined
the lumenal membrane.
(H–H00) A trc1 terminal cell clone (marked by GFP
[green]) expressing a hyperactive GckIII trans-
gene. A brightfield (BF) image is shown in (H0 ) and
the merged image (H00). The * indicates a transition
zone tube dilation; expression of hyperactive
GckIII failed to rescue transition zone dilations in
trc1 cells.
Scale bars, 20 mm in (D)–(H).
See also Figure S5 and Table S2.
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(Figures 6H–6H00 and Table S2).
Next, we assessed Trc activity in trachea using the antibody
that detects phosphorylation in the hydrophobic motif of hNDR8 Developmental Cell 47, 1–12, December 3, 2018kinases, a well-established readout to monitor the activity status
of human NDR1/2 (Hergovich, 2013). Specifically, we utilized an
antibody raised against the phosphorylated Thr444 site of NDR1
(Tamaskovic et al., 2003), which recognizes the equivalent site
Figure 7. Tricornered Activity in Trachea Requires Tao-1 and GckIII
(A–D) Third instar larval trachea stained with antibodies that recognize phosphorylation of the activation loop of Trc (P-Trc). GFP positive terminal cells are shown
of the following genotypes: (A–A%) wild-type; (B–B%) trc1; (C–C%) GckIIIwheezy; (D–D%) Tao-1eta. P-Trc is in magenta (A–D). Clones are marked by GFP (green) in
panels merged with brightfield images (A0, B0, C0, and D0 ). P-Trc (magenta) is merged with brightfield images (A00, B00, C00, and D00). Close-up images of P-Trc
(magenta) are shown in (A%), (B%), (C%), and (D%). GFP positive terminal cells are indicated by arrowheads. P-Trc is evident in puncta that line the apical
membrane of wild-type and control tracheal lumens. P-Trc staining is reduced or absent in trachea that aremutant for trc,GckIII or Tao-1 in (B)–(D). In (B)–(B%), the
asterisk indicates a control GFP negative terminal cell that stains positive for P-Trc and serves as an internal control. Scale bars, 10 mm.
(E) Tao-1 regulates two Hippo-like signaling modules. In addition to regulating Hippo-Warts signaling in organ growth, we have discovered that Tao-1 kinase
regulates a related Hippo-like pathway consisting of GckIII and Trc in morphogenesis.
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P-Trc). In wild-type trachea, P-Trc was evident in puncta lining
the apical membranes of terminal cells (Figures 7A–7A%). Impor-
tantly, this is the region where phenotypes caused by loss of
Tao-1,GckIII, or trcmanifest, e.g., tube dilation and accumulation
of septate junctionproteinsandCrumbs. Toconfirm the specificity
of this signal, we stained trc1mutant trachea and found complete
absence of this signal in GFP-positive trc1 mutant cells (asterisk,
Figures 7B–7B%). As an internal control for this experiment, a
wild-type terminal cell that neighbored the trc1 cell showed robust
P-Trc staining (arrowhead, Figures 7B–7B%). To determine
whether Trc activity was dependent on Tao-1 and GckIII, we
stained tracheal clones that were mutant for each of these genes.
As shown in Figures 7C–7D%, P-Trc signal was greatly reduced or
undetectable in Tao-1eta or GckIIIwheezy terminal cells. These re-
sults are consistent with our genetic epistasis experiments, which
show that Trc functions downstreamof Tao-1 andGckIII to control
tracheal morphogenesis (Table S2). Collectively, our genetic and
biochemical data indicate that we have identified a Hippo-like
pathway, consisting of the Tao-1,GckIII, and Trc kinases, that reg-
ulates tracheal development in D. melanogaster.DISCUSSION
Using genetic and biochemical experiments, we have defined
Tao-1 as a kinase that acts at the apex of two ancient and closely
related kinase modules that consist of a Sterile 20-like kinase
and an NDR family kinase: Hpo andWts; and GckIII and Trc (Fig-
ure 7E). Despite being similarly organized, Hippo-like kinase
modules execute distinct functions downstream of Tao-1. While
Hpo and Wts regulate organ size and cell fate, GckIII and Trc
regulate the architecture of trachea. Presumably, these differ-
ences can be explained by the substrates of the downstream ki-
nases in these signaling modules, Wts and Trc. A key step in
defining howHpo andWts regulate organ size was the discovery
that Wts phosphorylates the Yki transcription co-activator and
inhibits its nuclear access (Huang et al., 2005). Identifying the
substrate(s) of Trc is likely to offer similar mechanistic insights
into how the Hippo-like pathway of Tao-1/GckIII/Trc regulates
tracheal morphogenesis.
Of the many thousands of mutations analyzed in tracheal ter-
minal cells, less than a handful affect tube morphology specif-
ically in the transition zone (Baer et al., 2007; Beitel and Krasnow,Developmental Cell 47, 1–12, December 3, 2018 9
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Ruiz et al., 2012; Samakovlis et al., 1996). Among these we have
previously described mutations in lotus, which causes a local
transition zone tube discontinuity or gap, and mutations inGckIII
and Ccm3, which cause a local transition zone tube dilation
(Song et al., 2013). Intriguingly, mutations in Tao-1 cause both
defects. The only other genetic condition reported to have this
effect on terminal cell tubes is the combination of GckIII loss of
function and knockdown of the septate junction protein,
Varicose/PALS2 (Song et al., 2013). As in this case, loss of
Tao-1 appears to both compromise GckIII activity and septate
junction formation, given that Tao-1mutant tracheal cells exhibit
transition zone dilation and mislocalization of septate junction
proteins. These data suggest that Tao-1 performs at least two
functions to control tracheal morphology: (1) it acts upstream
of GckIII and Trc to prevent transition zone tube dilation; and
(2) it is required to maintain the integrity of septate junctions.
Trc appears to be the key substrate of GckIII, based on our
biochemical data and that the trc loss-of-function phenotype
closely phenocopies GckIII loss in trachea. Indeed, the trc tube
dilation phenotype is, if anything, more severe than for Ccm3
or GckIII, with trc mutant terminal cells often exhibiting multiple
large dilations in the transition zone. This would be consistent
with residual Trc activity inGckIIImutant backgrounds, suggest-
ing that additional Sterile-20 like kinases to GckIII may regulate
Trc activity in terminal tracheal cells. If so, this would parallel
regulation of D. melanogaster Wts and human LATS1 and
LATS2 in the Hippo pathway, where multiple Sterile-20 kinases
have been found to operate upstream of these NDR family
kinases (Meng et al., 2015; Zheng et al., 2015; Li et al., 2014; Li
et al., 2018).
In D. melanogaster, Trc also regulates polarized cell growth
that underpins hair and bristle development (Geng et al., 2000)
and tiling and branching of PNS dendrites (Emoto et al., 2004).
It will be interesting to determine whether Trc regulates the
same or similar proteins to control these different biological pro-
cesses or whether it regulates multiple proteins, akin to Wts,
which regulates Yki in the context of organ growth and R8 cell
fate choice, and the actin regulatory protein Enabled to control
border cell migration in the D. melanogaster ovary (Lucas et al.,
2013; Huang et al., 2005; Jukam et al., 2013). Furthermore, it
will be important to determine whether Tao-1 and GckIII operate
upstream of Trc in other biological settings. In addition to discov-
ering the key substrate(s) of Trc in trachea, defining modes of
upstream regulation of Tao-1 activity should provide insights
into how this Hippo-like signaling module controls tube develop-
ment. One candidate upstream regulator is Schip1, which has
been linked to Tao-1 and the Hippo pathway in the context of
organ size control (Chung et al., 2016), although the mechanism
by which it functions is unclear.
Previous findings by our group and others in both insects
and vertebrates established the human orthologs of GckIII
(MST3, MST4, and STK25) as potential disease genes in cerebral
cavernous malformation, a familial vascular syndrome charac-
terized by dilated leaky blood vessels (Song et al., 2013; Draheim
et al., 2014). hGCKIII kinases bind to the non-catalytic protein
CCM3, which is thought to serve as a scaffold for them. Theoret-
ically, CCM3 could promote the association of GCKIII kinases
with TAO kinases and/or NDR family kinases to facilitate their10 Developmental Cell 47, 1–12, December 3, 2018ability to phosphorylate one another and become active. This re-
quires further examination, but our findings raise the possibility
that the Tao-regulated Hippo-like signaling module identified
here is required for proper blood vessel formation in humans
and that aberrant activity of this module could contribute to
cerebral cavernousmalformation syndrome. If so, then our study
could provide potential therapeutic targets for treatment of this
disease.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Drosophila melanogaster stocks were maintained on standard medium at room temperature (22C) and experimental crosses were
carried out at 25C, unless otherwise indicated.
D. melanogaster S2R+ and S2 cells were maintained at 24C in Schneider‘s Medium (217200024, Invitrogen) supplemented with
heat inactivated FBS (10082147, Invitrogen) and penicillin/streptomycin.
HEK293 cells were grown at 37C in 5%CO2 humidified chambers in DMEM (D6429, Sigma) supplemented with 10% fetal bovine
serum (FBS; F7524, Sigma) and penicillin/streptomycin.
METHOD DETAILS
D. melanogaster Stocks
w; Taoeta FRT19A (Veit Riechmann)
w; FRT82B GckIIIwheezy770
w; FRT42D hpo5.1 (Nic Tapon)
w; FRT42D hpo42-47
w; trc1 FRT80B (Paul Adler)Developmental Cell 47, 1–12.e1–e5, December 3, 2018 e3
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opmental Cell (2018), https://doi.org/10.1016/j.devcel.2018.09.024y w eyFLP; FRT82B P[mini-w, ubi-GFP]
y w eyFlp, UAS-GFP; tub-GAL4, FRT42D, tub-GAL80
yw hsFLP122; FRT42D tub-GAL80; btl-Gal4, UAS-GFP
yw hsFLP122; btl-Gal4, UAS-GFP; FRT80B tub-Gal80
ywhsFLP122; FRT42D tub-Gal80; FRT82B GFPi
UAS-GFP RNAi, hsFLP122, FRT19A; btl-Gal4, UAS-GFP, UAS-DsREDnls
y w hsFLP122; btl-GAL4, UAS-DsREDnls; FRT82B cu UASi-GFPhp/TM6B
GAL4 lines: hh-GAL4, btl-GAL4, drm-GAL4 and rn-Gal4 (Bloomington Drosophila Stock Center).
UAS-RNAi lines: UAS-Tao-1 RNAi (VDRC GD 17432), UAS-Tao-1 RNAi (107645.8, modified VDRC KK 107645 that has a
P element-containing insertion removed from the 40D locus by meiotic recombination (Vissers et al., 2016), UAS-Trc RNAi (VDRC
KK 107923), UAS-GckIII RNAi (VDRC KK 107158), all Vienna Drosophila RNAi Center (Dietzl et al., 2007).
Other stocks: crumbs-GFPA (Yang Hong).
Transgenic flies: UAS-Tao-1HA is a dominant active form of Tao-1 that contains a deletion of residues 423-900 (Liu et al., 2010).
UAS-Tao-1HA flies were generated by subcloning V5-epitope tagged Tao-1D423-900 cDNA into pUAST. The pUAST-Tao-1D423-
900 DNA sequence was confirmed by Sanger sequencing and transgenic flies created by BestGene Inc. To generate UAS-GckIIIHA,
the wild typeGckIII cDNA was subjected to site directed mutagenesis (Quickchange, Agilent) to introduce a T to D coding change at
amino acid residue 167. The cDNA was cloned into the pUAST vector, injected into embryos (Rainbow Transgenic Flies) and
transgenic lines established. To generate an HA-epitope tagged UAS-GckIIIDN, HA-GckIIIT167A cDNA was generated by PCR
mutagenesis, cloned into the pTW vector via Gateway cloning (Thermo Fisher Scientific), confirmed by Sanger sequencing and
transgenic flies created by BestGene Inc.
Generation of Clones in Drosophila
For analysis of mosaic wing imaginal discs, clones were generated by heat shock on day 2 for 10minutes at 37C, incubating crosses
at 25Candwing discswere dissected frommosaic larvae on day 5. For analysis of mosaic trachea cells in larvae, cloneswere gener-
ated by heat shocking 0-4 hr old embryos for 1 hour at 38C, incubating crosses at 25C for 5 days and selecting third instar mosaic
larvae for analysis. Larvae were heat killed or filleted as described previously (Ghabrial et al., 2011).
Immunofluorescence
Primary antibodies were specific for DIAP1 (B. Hay), Varicose (E. Knust), Coracle, Fasciclin 3 (both DSHB), p-Thr444P (NDR1)
(Tamaskovic et al., 2003), cleaved Dcp1 (Cell Signalling) and anti-GFP (Abcam). Anti-rat, anti-Chicken and anti-mouse secondary
antibodies were from Invitrogen. Tissues were fixed and stained as in (Poon et al., 2012; Song et al., 2013).
Cell Proliferation Assay
EdU (5-ethynyl-2’deoxyuridine) incorporation assays were used to assess cell proliferation as in (Poon et al., 2016). Third instar eye
imaginal discs were dissected and subjected to 1 hour incubation with 10mM EdU/PBS, then fixed for 20 minutes in 4% formalde-
hyde/PBS. Incorporated EdU was detected by Click-iT fluorescent dye azide reaction in accordance to manufacturer’s instructions
(Life technologies).
Transient Transfections of Cultured Cells
Exponentially growing HEK293 cells were plated at a consistent confluence and transfected with plasmids using Fugene 6 (E2692,
Promega) according to the manufacturer’s instructions.
S2R+ cells were transiently transfected with pAW-based plasmids using Effectene (301425, Qiagen) according to the manufac-
turer’s instructions.
Expression Plasmids
The D. melanogaster Tao-1 open reading frame was cloned into the pMK33-NTAP-GS vector (Kyriakakis et al., 2008), to generate
N-terminally tagged Tao-1. D. melanogaster Tao-1 and human TAO1, MST3, MST4 and STK25 cDNAs were described (Hergovich
et al., 2009; Poon et al., 2011). The pAW vector and D. melanogaster GckIII cDNA (RE38276) were from the Drosophila Genomics
Resource Center (Indiana University, USA). pcDNA3_HA and pcDNA3_myc vectors were reported (Hergovich et al., 2005; Bettoun
et al., 2016). To generate N-terminally tagged cDNAs, human TAO1was subclonedwithBamHI and EcoRI intomodified pcDNA3_HA
or pcDNA3_myc.D.melanogaster Tao-1 andGckIII were subclonedwithBamHI and XhoI intomodified pcDNA3_HA or pcDNA_myc,
respectively. D. melanogaster GckIII kinase-dead (K42R) or activation loop phospho-acceptor (T167A) mutants were generated by
PCR mutagenesis using wild-type GckIII as a template. To subclone N-terminally tagged cDNAs into the pAW D. melanogaster
expression vector, tagged cDNAs were first inserted into the pENTR-3C plasmid (Invitrogen) and then recombined into the pAW
destination plasmid using Gateway technology (Invitrogen). All constructs were confirmed by Sanger sequencing.
Immunoblotting, Immunoprecipitations, and Antibodies
Immunoblotting and co-immunoprecipitation experiments were performed as described (Hergovich et al., 2005). The characteriza-
tion of Tao-1 and TAO1 binding to GCKIII kinases was carried out in low-stringency buffer as defined previously (Cook et al., 2014).e4 Developmental Cell 47, 1–12.e1–e5, December 3, 2018
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opmental Cell (2018), https://doi.org/10.1016/j.devcel.2018.09.024Anti-HA antibodies were fromCell Signaling (C29F4) andRoche (3F10). Anti-myc antibodies were fromSantaCruz Technology (9E10)
and Cell Signaling Technology (71D10). Anti-MST3 (611057) was from BD Biosciences, anti-MST4 (3822) was from Cell Signaling
Technology, anti-STK25 (sc-6865) and anti-actin (sc-1616) were from Santa Cruz Biotechnology. anti-Mal (Maltose binding protein;
E8032) is from New England BioLabs. The antibody detecting activation loop phosphorylation of GckIII (Thr167), MST3 (Thr190),
MST4 (Thr178) and STK25 (Thr174) was from Abcam and termed anti-T167-P or anti-GCKIII-P, respectively. The antibody detecting
hydrophobic motif phosphorylation of Trc (Thr449) has been described (Tamaskovic et al., 2003). Secondary antibodies were
purchased from GE Healthcare (NA931, NA934, and NA935) and Santa Cruz Biotechnology (sc-2020).
Mass Spectrometry
pMK33-NTAP-GS-Tao-1 was transfected intoD. melanogaster S2 cells and a stable cell line was selected using hygromycin. Protein
complexes containing Tao-1 and associated interactors were purified as in (Yang and Veraksa, 2017) and analysed by nanoLC-MS/
MS. Results from two independent biological replicates were compared to six independent controls using SAINT software (Choi
et al., 2011).
Kinase Assays
Full-length D. melanogaster GckIII and human MST3, MST4 or STK25 cDNAs were inserted into the pMal-c2 vector (New England
BioLabs) using BamHI and XhoI/SalI or XbaI sites to generate pMal-GckIII/GCKIII plasmids, which can express kinase-dead versions
that are N-terminally tagged by the maltose binding protein (Mal). The C-terminal hydrophobic fragments of D. melanogaster Trc
(residues 308 to 459), human NDR1 (residues 301 to 465) and NDR2 (residues 302 to 464) were inserted into the pMal-c2 vector using
BamHI and XhoI/SalI sites to generate pMal-Trc/NDR(HM) plasmids. Recombinant Mal-fusion proteins were expressed in E. coli
BL21(DE3) at 30C and purified using amylose resin (E8021, New England BioLabs) as described (Hergovich et al., 2005).
Recombinant full-length GST-MST1 (M9697; 07-116), GST-MST2 (S6573; 07-117), GST-MST3 (M9822; 07-118), GST-MST4
(M9947; 07-119) and GST-STK25 (SRP5087; 07-136) were from Sigma and Carna Biosciences, respectively. To produce immuno-
purified full-length HA-tagged Tao-1 or TAO1 kinase version, D. melanogaster S2R+ or human HEK293 cells were transfected with
pAW_HA-Tao1 or pcDNA3_HA-TAO1 and processed for immunoprecipitation (IP) using anti-HA antibody and stringent IP conditions
as described (Hergovich et al., 2005). Immunopurified proteins were washed twice with kinase buffer (50 mM Hepes pH 7.4, 10 mM
MgCl2, 2.5 mM beta-glycerophosphate, 1 mM EGTA, 1 mM Na3VO4, 1 mM NaF, 0.01 mM DTT), before kinase reactions were
performed as follows: per reaction, 200 ng of Mal-fusion proteins were incubated at 30C for 30 minutes in 20 ml of kinase
buffer containing 100 mM ATP in the absence or presence of immunopurified Tao-1, TAO1 or GCKIII or GST-tagged kinases
(100 ng per reaction). Reactions were stopped by the addition of Laemmli buffer, separated by SDS-PAGE, and immunoblotted
as outlined above.
QUANTIFICATION AND STATISTICAL ANALYSIS
In Figures S1E and S1J, control and experimental samples were analysed in one experiment. Adult posterior wing area and imaginal
disc clones were measured using Adobe Photoshop software (Adobe), and statistical analyses and graphs were plotted using Graph
Pad Prism (GraphPad software). Error bars represent standard error of mean (s.e.m.) and unpaired t-tests were used to assess
statistical differences, assuming Gaussian distribution and using two-tailed P value. n values are stated in legends. In Figure S1E,
the t-value (t) was 10.5 and the degree of freedom (df) was 25. In Figure S1J, the t and df values, respectively, are: control vs GckIII
Ri: t=1.76 df=8; control vs hpo5.1: t=6.469 df=7; hpo5.1 vs hpo5.1+ GckIII Ri: t=0.3452 df=6.
In Figures 1A, 1C, 1D, 2, 6B, and 6C, Western blots and kinase assays were repeated at least three times. In each experiment,
no statistical method was used to predetermine sample size, the experiments were not randomized and the investigators were
not blinded to allocation during experiments or outcome assessment.Developmental Cell 47, 1–12.e1–e5, December 3, 2018 e5
